Drug utilization study of anti-diabetic drugs
Phase 4
Completed
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellites
- Registration Number
- CTRI/2013/07/003839
- Lead Sponsor
- Dr Mirza Shiraz Baig
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 669
Inclusion Criteria
Records of Type-2 DM patients treated in Govt. Medical College, Aurangabad, from January to December 2010 were collected from medical records section. Anti-diabetic drugs, biguanides (metformin) sulphonylureas (glibenclamide) and other anti-diabetic drugs (insulin) commonly prescribed in diabetes management were studied and also its influence on age and co-morbidities were studied.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study prescription and utilization pattern of anti-diabetic drugsTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method To evaluate the influence of age and co-morbidities on prescription.Timepoint: 1 year